Skip to main content
. Author manuscript; available in PMC: 2011 Dec 6.
Published in final edited form as: Cancer Biomark. 2008;4(6):329–340. doi: 10.3233/cbm-2008-4605

Fig 6. Targeted microscopic imaging in vivo.

Fig 6

a) Conventional white light endoscopic image of colonic adenoma, and b) in vivo confocal fluorescence image collected after topical administration of FITC-labeled target peptide shows preferential binding to dysplastic colonocytes. The dysplasia:normal border shows an average target-to-background ratio of 21, scale bars 20 μm.